Biologic Glue for First Degree Perineal Tears
Randomized Control Trial for the Comparison of Biologic Glue Versus Suturing for First Degree Perineal Tears
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Jerusalem, Israel, 91120
- Hadassah Medical Organization
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- women after instrumental or normal vaginal delivery with a diagnosis of first degree perineal tears
Exclusion Criteria:
- excessive bleeding,
- chronic steroid treatment,
- immunosuppressive treatment,
- active infection,
- allergy to Dermabond or Histoacryl
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: 1
use of octyl-2-cyanoacrylate adhesive glue for perineal tear grade 1 in 80 women
|
adhesive of perineal tears
|
|
Active Comparator: 3
use of traditional suturing for perineal tear grade 1 in 50 women
|
suturing of perineal tears grade one with vicryl rapid 2X0
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Functional and cosmetic evaluation of perineal tear area.
Time Frame: At least six weeks after birth
|
At least six weeks after birth
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Assessment of pain at least six weeks after delivery
Time Frame: At least six weeks after delivery
|
At least six weeks after delivery
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Director: yosef ezra, M.D., hadassha medical organization, jerusalem israel
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
Other Study ID Numbers
- feigenberg HMO-CTIL
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.